These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19789336)

  • 1. RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.
    Kreeger PK; Mandhana R; Alford SK; Haigis KM; Lauffenburger DA
    Cancer Res; 2009 Oct; 69(20):8191-9. PubMed ID: 19789336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.
    Kikuchi H; Pino MS; Zeng M; Shirasawa S; Chung DC
    Cancer Res; 2009 Nov; 69(21):8499-506. PubMed ID: 19843849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
    Yu JA; Li H; Meng X; Fullerton DA; Nemenoff RA; Mitchell JD; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1479-85. PubMed ID: 23026567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics.
    Levidou G; Saetta AA; Gigelou F; Karlou M; Papanastasiou P; Stamatelli A; Kavantzas N; Michalopoulos NV; Agrogiannis G; Patsouris E; Korkolopoulou P
    World J Surg Oncol; 2012 Feb; 10():47. PubMed ID: 22376079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma.
    Mao JD; Wu P; Huang JX; Wu J; Yang G
    World J Gastroenterol; 2014 Sep; 20(35):12542-50. PubMed ID: 25253956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
    Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
    Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.
    Thamkachy R; Kumar R; Rajasekharan KN; Sengupta S
    Mol Cancer; 2016 Mar; 15():22. PubMed ID: 26956619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase antagonizes pro-apoptotic extracellular signal-regulated kinase activation by inducing dual-specificity protein phosphatases in response to glucose deprivation in HCT116 carcinoma.
    Kim MJ; Park IJ; Yun H; Kang I; Choe W; Kim SS; Ha J
    J Biol Chem; 2010 May; 285(19):14617-27. PubMed ID: 20220132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.
    Beck SE; Jung BH; Del Rosario E; Gomez J; Carethers JM
    Cell Signal; 2007 Jul; 19(7):1465-72. PubMed ID: 17317101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis.
    Basu Roy UK; Henkhaus RS; Loupakis F; Cremolini C; Gerner EW; Ignatenko NA
    Int J Cancer; 2013 Jul; 133(1):43-57. PubMed ID: 23280667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.
    Drosopoulos KG; Roberts ML; Cermak L; Sasazuki T; Shirasawa S; Andera L; Pintzas A
    J Biol Chem; 2005 Jun; 280(24):22856-67. PubMed ID: 15757891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α.
    Lau KS; Schrier SB; Gierut J; Lyons J; Lauffenburger DA; Haigis KM
    Integr Biol (Camb); 2013 Nov; 5(11):1355-65. PubMed ID: 24084984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.
    Case M; Matheson E; Minto L; Hassan R; Harrison CJ; Bown N; Bailey S; Vormoor J; Hall AG; Irving JA
    Cancer Res; 2008 Aug; 68(16):6803-9. PubMed ID: 18701506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation.
    Estrada Y; Dong J; Ossowski L
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):66-76. PubMed ID: 18983537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.
    Tseng YS; Lee JC; Huang CY; Liu HS
    BMC Cancer; 2009 Dec; 9():435. PubMed ID: 20003375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas.
    Kotoula V; Sozopoulos E; Litsiou H; Fanourakis G; Koletsa T; Voutsinas G; Tseleni-Balafouta S; Mitsiades CS; Wellmann A; Mitsiades N
    Endocr Relat Cancer; 2009 Jun; 16(2):565-72. PubMed ID: 19190079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas.
    Wei F; Liu Y; Bellail AC; Olson JJ; Sun SY; Lu G; Ding L; Yuan C; Wang G; Hao C
    Cancer Lett; 2012 Sep; 322(1):58-69. PubMed ID: 22342683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death.
    An HJ; Maeng O; Kang KH; Lee JO; Kim YS; Paik SG; Lee H
    J Biol Chem; 2006 Nov; 281(45):33939-48. PubMed ID: 16954213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.